Literature DB >> 21470827

Antiepileptic effects of endogenous beta-hydroxybutyrate in suckling infant rats.

Marat Minlebaev1, Rustem Khazipov.   

Abstract

Physiological ketosis is a hallmark of metabolism in suckling infants. However, little is known on the impact of physiological ketosis on brain excitability. We addressed this question in suckling rats in vivo. 16-channel extracellular field potential recordings were performed from somatosensory barrel cortex at postnatal days 5-9 non-anaesthetized rat pups. Seizures were induced by the volatile convulsant agent flurothyl. One hour after blockade of physiological ketogenesis using combined administration of beta-oxidation inhibitors mercaptoacetate, insulin and glucose to prevent hypoglycemia, we found no significant change in the flurothyl-induced electrographic seizures. However, build-up of seizures during two repetitive flurothyl applications was strongly aggravated in the animals with blocked ketogenesis. The effect of ketogenesis inhibitors was reversed by exogenous beta-hydroxybutyrate. Diazepam exerted anticonvulsive action both under physiological ketosis and after blockade of ketogenesis, and bumetanide had no significant anticonvulsive effects in both conditions. Thus, physiological ketosis reduces excitability in the immature brain and elimination of physiological ketosis results in elimination of this anticonvulsant effect. Our study raises concern that the changes in diet, and pharmacological manipulations such as glucose infusion, and pathologies such as hyperinsulinism which break natural ketosis, may be a potential risk factor for epileptogenesis in nursing infants.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21470827     DOI: 10.1016/j.eplepsyres.2011.03.003

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  16 in total

Review 1.  Ketone bodies in epilepsy.

Authors:  Melanie A McNally; Adam L Hartman
Journal:  J Neurochem       Date:  2012-02-07       Impact factor: 5.372

Review 2.  Do ketone bodies mediate the anti-seizure effects of the ketogenic diet?

Authors:  Timothy A Simeone; Kristina A Simeone; Carl E Stafstrom; Jong M Rho
Journal:  Neuropharmacology       Date:  2018-01-08       Impact factor: 5.250

Review 3.  Depolarizing GABA and developmental epilepsies.

Authors:  Roustem Khazipov; Guzel Valeeva; Ilgam Khalilov
Journal:  CNS Neurosci Ther       Date:  2014-12-01       Impact factor: 5.243

4.  Energy substrates protect hippocampus against endogenous glutamate-mediated neurodegeneration in awake rats.

Authors:  Citlalli Netzahualcoyotzi; Ricardo Tapia
Journal:  Neurochem Res       Date:  2014-05-01       Impact factor: 3.996

Review 5.  Ketone Bodies as Anti-Seizure Agents.

Authors:  Timothy A Simeone; Kristina A Simeone; Jong M Rho
Journal:  Neurochem Res       Date:  2017-04-10       Impact factor: 3.996

Review 6.  GABAergic Synchronization in Epilepsy.

Authors:  Roustem Khazipov
Journal:  Cold Spring Harb Perspect Med       Date:  2016-01-08       Impact factor: 6.915

7.  Segregation of seizures and spreading depolarization across cortical layers.

Authors:  Andrey Zakharov; Kseniya Chernova; Gulshat Burkhanova; Gregory L Holmes; Roustem Khazipov
Journal:  Epilepsia       Date:  2019-11-21       Impact factor: 5.864

8.  Anticonvulsant effect of exogenous β-hydroxybutyrate on kainic acid-induced epilepsy.

Authors:  Jianping Si; Shaohui Wang; Ning Liu; Xiaofei Yang; Ying Wang; Ling Li; Jiwen Wang; Xin Lv
Journal:  Exp Ther Med       Date:  2017-06-07       Impact factor: 2.447

Review 9.  Neuroketotherapeutics: A modern review of a century-old therapy.

Authors:  Scott J Koppel; Russell H Swerdlow
Journal:  Neurochem Int       Date:  2017-06-01       Impact factor: 3.921

10.  Refuting the challenges of the developmental shift of polarity of GABA actions: GABA more exciting than ever!

Authors:  Yehezkel Ben-Ari; Melanie A Woodin; Evelyne Sernagor; Laura Cancedda; Laurent Vinay; Claudio Rivera; Pascal Legendre; Heiko J Luhmann; Angelique Bordey; Peter Wenner; Atsuo Fukuda; Anthony N van den Pol; Jean-Luc Gaiarsa; Enrico Cherubini
Journal:  Front Cell Neurosci       Date:  2012-08-28       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.